Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.
To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Platelet activating factor
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).
Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).
Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Ramesha CS and Pickett WC | Human neutrophil platelet-activating factor: molecular heterogeneity in unstimulated and ionophore-stimulated cells. | 1987 | Biochim. Biophys. Acta | pmid:3113489 |
Bolin RW et al. | Lung endothelial and epithelial permeability after platelet-activating factor. | 1987 | J. Appl. Physiol. | pmid:3693212 |
Robertson DA et al. | Negative inotropic effect of platelet-activating factor on human myocardium: a pharmacological study. | 1987 | J. Pharmacol. Exp. Ther. | pmid:3694533 |
Nomura H | Biological action and structural specificity of diacylglycerol in platelet activation. | 1987 | Kobe J Med Sci | pmid:3695296 |
Alam I and Silver MJ | Metabolism of 1-alkyl-2-acyl-GPC in human platelets in response to stimulation by thrombin. | 1987 | Thromb. Res. | pmid:3576519 |
Kusner EJ et al. | Pharmacologic analysis of 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced increases in cutaneous vascular permeability in the rat. | 1987 | Agents Actions | pmid:3577957 |
Chesney CM et al. | Triazolobenzodiazepines competitively inhibit the binding of platelet activating factor (PAF) to human platelets. | 1987 | Biochem. Biophys. Res. Commun. | pmid:3579913 |
Kawasaki T and Snyder F | The metabolism of lyso-platelet-activating factor (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by a calcium-dependent lysophospholipase D in rabbit kidney medulla. | 1987 | Biochim. Biophys. Acta | pmid:3036238 |
Shukla SD et al. | Activation of phospholipase C in platelets by platelet activating factor and thrombin causes hydrolysis of a common pool of phosphatidylinositol 4,5-bisphosphate. | 1987 | Biochim. Biophys. Acta | pmid:3036249 |
Casals-Stenzel J | Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock. | 1987 | Eur. J. Pharmacol. | pmid:3582490 |
Fouque F and Vargaftig BB | Potentiation and inhibition by clonidine of PAF-acether-induced human platelet activation. | 1987 | Eur. J. Pharmacol. | pmid:3582495 |
Grignani G and Jamieson GA | Tissue factor-dependent activation of platelets by cells and microvesicles of SK-OS-10 human osteogenic sarcoma cell line. | 1987 | Invasion Metastasis | pmid:3036740 |
Lellouch-Tubiana A et al. | Interactions between granulocytes and platelets with the guinea-pig lung in passive anaphylactic shock. Correlations with PAF-acether-induced lesion. | 1987 | Int. Arch. Allergy Appl. Immunol. | pmid:3583412 |
Snyder F et al. | Measurement of key enzyme activities involved in the metabolism of platelet activating factor. | 1987 | Meth. Enzymol. | pmid:3037250 |
Patterson R et al. | Evaluation of the effect of a platelet activating factor antagonist on platelet activating factor and Ascaris antigen-induced airway responses in rhesus monkeys. | 1987 | J. Lab. Clin. Med. | pmid:3668360 |
Ingraham LM et al. | In vitro and in vivo effects of treatment by platelet-activating factor on N-formyl-met-leu-phe-mediated responses of polymorphonuclear leucocytes. | 1987 | Br. J. Haematol. | pmid:3038160 |
O'Flaherty JT et al. | 1-O-alkyl-2-N-methylcarbamyl-glycerophosphocholine: a biologically potent, non-metabolizable analog of platelet-activating factor. | 1987 | Biochem. Biophys. Res. Commun. | pmid:2820395 |
Whittle BJ et al. | Gastric vascular and mucosal damaging actions of platelet activating factor in the canine stomach. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2959063 |
Englberger W et al. | Influence of lysophospholipids and PAF on the oxidative burst of PMNL. | 1987 | Int. J. Immunopharmacol. | pmid:3038761 |
Wymann MP et al. | Oscillatory motion in human neutrophils responding to chemotactic stimuli. | 1987 | Biochem. Biophys. Res. Commun. | pmid:2820398 |
Handley DA et al. | Inhibition by SRI 63-072 and SRI 63-119 of PAF-acether and immune complex effects in the guinea pig. | 1987 | Eur. J. Pharmacol. | pmid:2959489 |
Doly M et al. | Effects of platelet-activating factor on electrophysiology of isolated retinas and their inhibition by BN 52021, a specific PAF-acether receptor antagonist. | 1987 | Immunopharmacology | pmid:3038784 |
Montrucchio G et al. | In vitro oxytocic activity of platelet-activating factor on human myometrium. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2960158 |
Homma H et al. | Binding and internalization of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine in washed rabbit platelets. | 1987 | J. Biol. Chem. | pmid:3038889 |
Mallet AI et al. | Platelet activating factor in chronic plaque psoriasis. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2960170 |
Bourgain RH et al. | Effect of ginkgolide PAF-acether antagonists on arterial thrombosis. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2960196 |
Braquet P et al. | Platelet-activating factor: a potential mediator of shock. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2960197 |
Myers A et al. | Pharmacological manipulation of platelet-activating factor toxicity in rodents. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2960198 |
Woodard DS et al. | The final step in the de novo biosynthesis of platelet-activating factor. Properties of a unique CDP-choline:1-alkyl-2-acetyl-sn-glycerol choline-phosphotransferase in microsomes from the renal inner medulla of rats. | 1987 | J. Biol. Chem. | pmid:3029085 |
Adamson LM et al. | Mechanistic studies of early pregnancy associated thrombocytopenia (EPAT) in the mouse. | 1987 | Am J Reprod Immunol Microbiol | pmid:3605486 |
Edwards MC et al. | Secretion and properties of a polypeptide factor generated by phorbol ester stimulation of human blood platelets. | 1987 | Biochem. Pharmacol. | pmid:3606649 |
Sturk A et al. | Age-related deficiency of the synthesis of platelet activating factor by leukocytes from Zellweger patients. | 1987 | Blood | pmid:3607283 |
Martins MA et al. | Interactions between local inflammatory and systemic haematological effects of PAF-acether in the rat. | 1987 | Eur. J. Pharmacol. | pmid:3609124 |
Mangold HK et al. | Biologically active lipids. Semi-synthesis of 3H-labeled ether glycerophospholipids and ether glyceroglycolipids from ratfish liver oil. | 1987 | FEBS Lett. | pmid:3609315 |
Bamford CH et al. | Polymeric inhibitors of platelet aggregation. II. Copolymers of dipyridamole and related drugs with N-vinylpyrrolidone. | 1987 | Biochim. Biophys. Acta | pmid:3828396 |
Casals-Stenzel J | Effects of WEB 2086, a novel antagonist of platelet activating factor, in active and passive anaphylaxis. | 1987 | Immunopharmacology | pmid:3597059 |
Handley DA et al. | Biological properties of the antagonist SRI 63-441 in the PAF and endotoxin models of hypotension in the rat and dog. | 1987 | Immunopharmacology | pmid:3597060 |
Casals-Stenzel J et al. | Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. | 1987 | J. Pharmacol. Exp. Ther. | pmid:3598913 |
Tokumura A et al. | Platelet aggregation induced by ether-linked phospholipids. 1. Inhibitory actions of bovine serum albumin and structural analogues of platelet activating factor. | 1987 | Thromb. Res. | pmid:3647677 |
Rola-Pleszczynski M et al. | Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet activating factor (PAF-acether): reversal by a specific antagonist, BN 52021. | 1987 | Biochem. Biophys. Res. Commun. | pmid:3493773 |
Dewald B and Baggiolini M | Evaluation of PAF antagonists using human neutrophils in a microtiter plate assay. | 1987 | Biochem. Pharmacol. | pmid:3649232 |
Adler KB et al. | Platelet activating factor stimulates secretion of mucin by explants of rodent airways in organ culture. | 1987 | Exp. Lung Res. | pmid:3653044 |
Nakayama R et al. | Existence of endogenous inhibitors of platelet-activating factor (PAF) with PAF in rat uterus. | 1987 | J. Biol. Chem. | pmid:3654606 |
Taylor RR et al. | Whole blood platelet aggregation is not affected by cigarette smoking but is sex-related. | 1987 | Clin. Exp. Pharmacol. Physiol. | pmid:3440324 |
Shimazaki N et al. | Diketopiperazines as a new class of platelet-activating factor inhibitors. | 1987 | J. Med. Chem. | pmid:3656347 |
Knox P et al. | Role of plasminogen, plasmin, and plasminogen activators in the migration of fibroblasts into plasma clots. | 1987 | J. Cell. Physiol. | pmid:2958486 |
Kudo I et al. | Antitumor activity of synthetic alkylphospholipids with or without PAF activity. | 1987 | Lipids | pmid:3444379 |
Söling U et al. | Effect of synthetic phospholipids on platelet aggregation and serotonin release. | 1987 | Lipids | pmid:3444380 |
Schick HD et al. | Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro. | 1987 | Lipids | pmid:3444383 |
Danhauser S et al. | Structure-cytotoxicity studies on alkyl lysophospholipids and some analogs in leukemic blasts of human origin in vitro. | 1987 | Lipids | pmid:3444384 |
Oon SH and Williams N | Immature megakaryocytes in the mouse: synergistic response to megakaryocyte potentiator, thrombopoietic stimulatory factor with interleukin 3. | 1987 | Leukemia | pmid:3500375 |
Pretolani M et al. | Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs. | 1987 | Eur. J. Pharmacol. | pmid:3653247 |
Hurst JS et al. | Effects of the lipid peroxidation product 4-hydroxynonenal on the aggregation of human platelets. | 1987 | Chem. Biol. Interact. | pmid:3103933 |
Grigorian GY and Ryan US | Platelet-activating factor effects on bovine pulmonary artery endothelial cells. | 1987 | Circ. Res. | pmid:3040294 |
Morganroth ML et al. | Decreased pulmonary vascular responsiveness in rats raised on an essential fatty acid deficient diet. | 1987 | Prostaglandins | pmid:3108962 |
Levin M et al. | Platelet immune complex interaction in the pathogenesis of Kawasaki disease. | 1987 | Prog. Clin. Biol. Res. | pmid:3423040 |
Violi F et al. | Human platelet aggregation by PAF and thromboxane production. | 1987 | Thromb. Res. | pmid:3424290 |
Muirhead EE | Vasodepressor lipid of the renomedullary interstitial cells of the renal papilla is a prohormone activated by the liver. | 1987 | Agents Actions Suppl. | pmid:3324720 |
Mest HJ et al. | Relevance of eicosanoids for biochemical regulation of cardiac rhythm disturbances. | 1987 | Biomed. Biochim. Acta | pmid:3325045 |
Bloom JW et al. | Intravenous platelet activating factor does not affect lung epithelial permeability. | 1987 | Res. Commun. Chem. Pathol. Pharmacol. | pmid:3326081 |
Braquet P and Bourgain RH | Anti-anaphylactic properties of BN 52021: a potent platelet activating factor antagonist. | 1987 | Adv. Exp. Med. Biol. | pmid:3314403 |
Barnes PJ | New concepts in the pathogenesis of bronchial hyperresponsiveness. | 1987 | Agents Actions Suppl. | pmid:3314413 |
Mustard JF et al. | Platelet activation--an overview. | 1987 | Agents Actions Suppl. | pmid:3314414 |
Page CP and Robertson DN | Properties of PAF relevant to asthma. | 1987 | Agents Actions Suppl. | pmid:3314416 |
Steel G et al. | Failure of prostaglandin E2 and its 16,16-dimethyl analogue to prevent the gastric mucosal damage induced by Paf. | 1987 | Br. J. Pharmacol. | pmid:3470106 |
Morley J | PAF and airway hyperreactivity; prospects for novel prophylactic anti-asthma drugs. | 1987 | Agents Actions Suppl. | pmid:3314417 |
Braquet P et al. | The role of PAF-acether in anaphylaxis demonstrated with the use of the antagonist BN 52021. | 1987 | Agents Actions Suppl. | pmid:3314418 |
Rubin AH et al. | The bronchoconstrictor properties of platelet-activating factor in humans. | 1987 | Am. Rev. Respir. Dis. | pmid:3314611 |
Wang J and Dunn MJ | Platelet-activating factor mediates endotoxin-induced acute renal insufficiency in rats. | 1987 | Am. J. Physiol. | pmid:2827506 |
Panetta T et al. | Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: inhibition of ischemia-reperfusion induced cerebral injury. | 1987 | Biochem. Biophys. Res. Commun. | pmid:2827647 |
Bazan HE et al. | The accumulation of platelet activating factor in the injured cornea may be interrelated with the synthesis of lipoxygenase products. | 1987 | Biochem. Biophys. Res. Commun. | pmid:2827658 |
Tamura N et al. | Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects. | 1987 | Biochem. Biophys. Res. Commun. | pmid:3030295 |
Czarnetzki BM | [Mediators and the bronchial system. Pathophysiologic and biochemical aspects of mediators of the bronchial system]. | 1987 | Wien Med Wochenschr Suppl | pmid:3078398 |
O'Flaherty JT | Phospholipid metabolism and stimulus-response coupling. | 1987 | Biochem. Pharmacol. | pmid:3030324 |
Korth R and Benveniste J | BN 52021 displaces [3H]paf-acether from, and inhibits its binding to intact human platelets. | 1987 | Eur. J. Pharmacol. | pmid:3428349 |
Steiger J et al. | Platelet activating factor (PAF) is a potent stimulator of porcine tracheal fluid secretion in vitro. | 1987 | Eur. J. Pharmacol. | pmid:3428351 |
Karasawa K et al. | Antibody to platelet activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine; PAF). | 1987 | J. Biochem. | pmid:3429442 |
Stahl GL et al. | PAF-acether induced cardiac dysfunction in the isolated perfused guinea pig heart. | 1987 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:3431598 |
Spinnewyn B et al. | Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in Mongolian gerbils. | 1987 | Prostaglandins | pmid:3432553 |
Guinot P et al. | Effect of BN 52063, a specific PAF-acether antagonist, on bronchial provocation test to allergens in asthmatic patients. A preliminary study. | 1987 | Prostaglandins | pmid:3432562 |
Hayashi M et al. | Detection of platelet-activating factor in exudates of rats with phorbol myristate acetate-induced pleurisy. | 1987 | Thromb. Res. | pmid:3433255 |
Kurachi M et al. | Suppression of bronchial response to platelet activating factor following taurine administration. | 1987 | Adv. Exp. Med. Biol. | pmid:3434419 |
Chung KF et al. | Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man. | 1987 | Lancet | pmid:2880069 |
Adnot S et al. | Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets. | 1987 | Agents Actions | pmid:3115070 |
Montrucchio G et al. | The pattern of cardiovascular alterations induced by infusion of platelet-activating factor in rabbit is modified by pretreatment with H1-H2 receptor antagonists but not by cyclooxygenase inhibition. | 1987 | Agents Actions | pmid:3115072 |
Evans TW et al. | Effect of platelet-activating factor on airway vascular permeability: possible mechanisms. | 1987 | J. Appl. Physiol. | pmid:3115939 |
Knudsen BS et al. | Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells. | 1987 | J. Clin. Invest. | pmid:3116043 |
Bussolino F et al. | Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures. | 1987 | J. Immunol. | pmid:3116081 |
Bitterman H et al. | Beneficial actions of RO 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock. | 1987 | Methods Find Exp Clin Pharmacol | pmid:3116357 |
Gateau O | [Role of PAF-acether (platelet activating factor) in cardio-vascular pathology]. | 1987 | Arch Mal Coeur Vaiss | pmid:3117010 |
Altin JG et al. | Evidence that Ca2+ fluxes and respiratory, glycogenolytic and vasoconstrictive effects induced by the action of platelet-activating factor and L-alpha-lysophosphatidylcholine in the perfused rat liver are mediated by products of the cyclo-oxygenase pathway. | 1987 | Biochem. J. | pmid:3117040 |
Bertani T et al. | Platelet activating factor (PAF) as a mediator of injury in nephrotoxic nephritis. | 1987 | Kidney Int. | pmid:3039232 |
PAF, platelets and asthma. Proceedings of a meeting. September 7-9, 1986. | 1987 | Agents Actions Suppl. | pmid:3478993 | |
Farr RS et al. | Platelet abnormalities in asthma--do they exist in humans? | 1987 | Agents Actions Suppl. | pmid:3478994 |
Moodley I and Stuttle A | Evidence for a dual pathway in platelet activating factor-induced aggregation of rat polymorphonuclear leucocytes. | 1987 | Prostaglandins | pmid:3035617 |
Menz G et al. | Lack of PAF release in extrinsic asthma. | 1987 | Agents Actions Suppl. | pmid:3478995 |
Szczeklik A et al. | Bleeding time and PAF-acether-induced platelet aggregation in atopy. | 1987 | Agents Actions Suppl. | pmid:3478996 |
Schmitz-Schumann M et al. | Evidence of PAF release and platelet activation in analgesics-asthma-syndrome. | 1987 | Agents Actions Suppl. | pmid:3478999 |
Guinot P et al. | Effects of BN 52063 on PAF-acether induced weal and flare in man. | 1987 | Agents Actions Suppl. | pmid:3479000 |
Lang M et al. | Effects of the PAF-antagonist CV-3988 on PAF-induced changes in mucus secretion and in respiratory and circulatory variables in ferrets. | 1987 | Agents Actions Suppl. | pmid:3479001 |